These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20041987)

  • 1. Melatonin interactions with blood pressure and vascular function during L-NAME-induced hypertension.
    Paulis L; Pechanova O; Zicha J; Barta A; Gardlik R; Celec P; Kunes J; Simko F
    J Pineal Res; 2010 Mar; 48(2):102-8. PubMed ID: 20041987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor.
    Paulis L; Zicha J; Kunes J; Hojna S; Behuliak M; Celec P; Kojsova S; Pechanova O; Simko F
    Hypertens Res; 2008 Apr; 31(4):793-803. PubMed ID: 18633192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular effects of long-term propranolol administration after chronic nitric oxide blockade.
    Priviero FB; Teixeira CE; Claudino MA; De Nucci G; Zanesco A; Antunes E
    Eur J Pharmacol; 2007 Oct; 571(2-3):189-96. PubMed ID: 17610863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin improves the restoration of endothelium-derived constricting factor signalling and inner diameter in the rat femoral artery after cessation of L-NAME treatment.
    Paulis L; Pechanova O; Zicha J; Liskova S; Celec P; Mullerova M; Kollar J; Behuliak M; Kunes J; Adamcova M; Simko F
    J Hypertens; 2010 Sep; 28 Suppl 1():S19-24. PubMed ID: 20823712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmented endothelium-derived hyperpolarizing factor-mediated relaxations attenuate endothelial dysfunction in femoral and mesenteric, but not in carotid arteries from type I diabetic rats.
    Shi Y; Ku DD; Man RY; Vanhoutte PM
    J Pharmacol Exp Ther; 2006 Jul; 318(1):276-81. PubMed ID: 16565165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic low-dose L-NAME treatment effect on cardiovascular system of borderline hypertensive rats: feedback regulation?
    Kopincova J; Puzserova A; Bernatova I
    Neuro Endocrinol Lett; 2008 Oct; 29(5):784-9. PubMed ID: 18987608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic N-acetylcysteine administration prevents development of hypertension in N(omega)-nitro-L-arginine methyl ester-treated rats: the role of reactive oxygen species.
    Rauchová H; Pechánová O; Kunes J; Vokurková M; Dobesová Z; Zicha J
    Hypertens Res; 2005 May; 28(5):475-82. PubMed ID: 16156512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2.
    Henrion D; Dechaux E; Dowell FJ; Maclour J; Samuel JL; Lévy BI; Michel JB
    Br J Pharmacol; 1997 May; 121(1):83-90. PubMed ID: 9146891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of N-acetylcysteine and melatonin in adult spontaneously hypertensive rats with established hypertension.
    Pechánová O; Zicha J; Paulis L; Zenebe W; Dobesová Z; Kojsová S; Jendeková L; Sládková M; Dovinová I; Simko F; Kunes J
    Eur J Pharmacol; 2007 Apr; 561(1-3):129-36. PubMed ID: 17321519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive mechanisms of chronic captopril or N-acetylcysteine treatment in L-NAME hypertensive rats.
    Zicha J; Dobesová Z; Kunes J
    Hypertens Res; 2006 Dec; 29(12):1021-7. PubMed ID: 17378375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EDHF-mediated rapid restoration of hypotensive response to acetylcholine after chronic, but not acute, nitric oxide synthase inhibition in rats.
    Desai KM; Gopalakrishnan V; Hiebert LM; McNeill JR; Wilson TW
    Eur J Pharmacol; 2006 Sep; 546(1-3):120-6. PubMed ID: 16876156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
    Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
    Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats.
    Paulis L; Pechanova O; Zicha J; Krajcirovicova K; Barta A; Pelouch V; Adamcova M; Simko F
    J Hypertens Suppl; 2009 Aug; 27(6):S11-6. PubMed ID: 19633445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic ouabain treatment exacerbates blood pressure elevation in spontaneously hypertensive rats: the role of vascular mechanisms.
    Xavier FE; Davel AP; Fukuda LE; Rossoni LV
    J Hypertens; 2009 Jun; 27(6):1233-42. PubMed ID: 19337130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of smooth muscle function of rat thoracic aorta in an endothelium-independent manner by long-term administration of N(G)-nitro-L-arginine methyl ester.
    López RM; Ortíz CS; Ruíz A; Vélez JM; Castillo C; Castillo EF
    Fundam Clin Pharmacol; 2004 Dec; 18(6):669-77. PubMed ID: 15548238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin protects myocardium from ischemia-reperfusion injury in hypertensive rats: role of myeloperoxidase activity.
    Sahna E; Deniz E; Bay-Karabulut A; Burma O
    Clin Exp Hypertens; 2008 Oct; 30(7):673-81. PubMed ID: 18855270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive responses elicited by central moxonidine in rats: possible role of nitric oxide.
    Moreira TS; Takakura AC; Sato MA; Menani JV; Colombari E
    J Cardiovasc Pharmacol; 2006 Jun; 47(6):780-7. PubMed ID: 16810079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of chronic inhibition of nitric oxide synthesis on vascular structure: remodeling or growth?].
    Moreau P; Takase H; Küng CF; Lüscher TF
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1141-3. PubMed ID: 8572861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ouabain treatment changes the role of endothelial factors in rat resistance arteries.
    Padilha AS; Peçanha FM; Vassallo DV; Alonso MJ; Salaices M
    Eur J Pharmacol; 2008 Dec; 600(1-3):110-6. PubMed ID: 18976649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.